BD (Becton, Dickinson and Company) received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA) for the BD Veritor At-Home COVID-19 Test, a rapid antigen test that uses computer vision technology in a smartphone app to interpret results and then provide a digital display of those results to users.
The test does not require a prescription or a laboratory to process the tests.
The digitally read, lateral flow antigen test will initially be made available to businesses, schools and governments looking to provide a self-testing option for employees or students.
The test uses a nasal swab and a mobile app from Scanwell Health, yielding test results in 15 minutes. The app is available on iOS and Android and provides step-by-step instructions on how to collect and transfer the nasal swab sample to the test stick. The mobile device's camera is then used to capture, analyze and interpret the results.
It is recommended that people 14 years of age or older perform the test, but the test can be used for children as young as 2-years-old when collected by an adult. Video instructions guide users through each step with built-in timers.
